Cambridge Laboratories bought by Alliance9th February 2010
Drug firm Alliance Pharma has announced that it plans to purchase the majority of Cambridge Laboratories.
The deal is estimated to be worth between £14-16 million. John Dawson, chief executive of Alliance Pharma, said: "It’s a business that matches us very well. They’ve got a bedrock of products which are quite self sustaining just like we have. They’ve got an oncology unit that provides some growth through marketing activities so it’s a very good match, and it gives us quite a boost in scale. It’s the biggest acquisition we’ve done yet. It’s our 18th in 12 years."
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Cambridge Laboratories bought by Alliance
Author: Jess Laurence
Article Id: 14003
Date Added: 9th Feb 2010